Neighbourly Pharmacy, a Toronto-based network of community pharmacies, has priced its initial public offering of common shares on the Toronto Stock Exchange. It expects to raise gross proceeds of about C$175 million, based on an offering at C$17 per share. A greenshoe option, if fully exercised, would provide about C$26 million to selling shareholders. Neighbourly is backed by Persistence Capital Partners.
TORONTO, May 18, 2021 /CNW/ – Neighbourly Pharmacy Inc. (“Neighbourly” or the “Company”), Canada’s largest and fastest growing network of community pharmacies, today announced that it has filed, and obtained a receipt for, its final prospectus filed with the securities regulatory authorities in each of the provinces and territories of Canada (the “Final Prospectus”) and has entered into an underwriting agreement in respect of its initial public offering (the “Offering”). The Offering consists of a treasury offering of 10,295,000 common shares of the Company at a price of $17.00 per common share (the “Offering Price”) for total gross proceeds to the Company of approximately $175 million. The offering size was increased from approximately $150 million to $175 million. An over-allotment option has been granted and, if exercised, will result in a secondary offering by certain shareholders of the Company (the “Selling Shareholders”). If the over-allotment option is exercised in full, the Selling Shareholders will receive aggregate gross proceeds of approximately $26 million. The Offering is expected to close May 25, 2021, subject to customary closing conditions.
The Toronto Stock Exchange (“TSX”) has conditionally approved the listing of the Company’s common shares, subject to fulfillment by the Company of all of the initial listing requirements and conditions of the TSX. The Company’s common shares are expected to begin trading on the TSX upon closing of the Offering under the symbol “NBLY”.
In addition to the Offering, pursuant to a subscription agreement entered into between the Company and Rx Sidecar II, L.P. (the “Investor”), the Investor has agreed to purchase, on a prospectus-exempt basis in Canada, 1,058,823 common shares of the Company at the Offering Price for additional aggregate gross proceeds to the Company of $18 million (the “Concurrent Private Placement”). Closing of the Concurrent Private Placement is scheduled to occur concurrently with the closing of the Offering and is conditional upon closing of the Offering.
The Offering is led by Scotiabank, RBC Capital Markets and BMO Capital Markets, together with a syndicate comprised of National Bank Financial Inc., TD Securities Inc., Desjardins Capital Markets, iA Private Wealth Inc., and HSBC.
Copies of the Final Prospectus are available on SEDAR at www.sedar.com.
No securities regulatory authority has either approved or disapproved of the contents of this news release. The Company’s common shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws. Accordingly, the Company’s common shares may not be offered, sold or delivered within the United States unless pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of Neighbourly in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About Neighbourly Pharmacy Inc.
Neighbourly is Canada’s largest and fastest growing network of community pharmacies. United by their patient first focus and their role as essential and trusted healthcare hubs within their communities, Neighbourly’s pharmacies strive to provide accessible healthcare with a personal touch. Since 2015, Neighbourly has expanded its diversified national footprint to include 145 locations, reinforcing the Company’s reputation as the industry’s acquirer of choice.